Regional Update 2 Financial Report 3 Governance Report 4.

Slides:



Advertisements
Similar presentations
An Introduction to Multiple Sclerosis. What is MS? Common symptoms. Diagnosis & potential treatments. Case Studies Support for people with MS and carers.
Advertisements

This presentation will ‘walk’ you through the pathway and guide you on how to use this tool.
© INTERNATIONAL GLAUCOMA ASSOCIATION (274681) 2009 The International GLAUCOMA Association Subhash Suthar D Pharm Development Manager.
MIGSYS Ian Evans, Genetics Max Musicant, SOM Grant Patterson, EPH Jia Kang, Med Informatics Colin Shaw, Nursing YBPS Case Competition November 20, 2009.
1 BrainStorm is a leading developer of stem cell technologies to provide treatments for currently incurable neurodegenerative.
Impact of HTA Therapeutic Reviews on Real World Clinical Practice: The MS Society of Canada’s Perspective Dr. Karen Lee, Vice-President Research.
REGENERATION OF BONE TISSUE THROUGH STEM CELLS FOR THE TREATMENT OF OSTEOARTHRITIS Allen Wang and Sravan Rajathilak Arthritis Arthritis is a degenerative.
Influencing Change in Research, Treatment Protocols, and New Drug Development.
Multiple Sclerosis Definition: Multiple sclerosis (MS) is a disease of the central nervous system (CNS); it damages the protective coating around the.
1 Welcome To Rural Sociology 2225 “Science, Technology and Society” Mary Grigsby Associate Professor of Rural Sociology Division of Applied Social Sciences.
IRB PRESENTATION REGULATORY PATHWAYS HDE – PMA William Hellenbrand MD Director – Pediatric Cardiology Columbia University College of Physicians & Surgeons.
The Accelerated Cure Project for MS 1 Suffolk University November 7 th, 2011 Robert N. McBurney, Chief Executive Officer A New Model to Speed the Pace.
“Biogen Idec: Evaluating a Potential Acquisition”
The Application of the Scientific Method: Preclinical Trials Copyright PEER.tamu.edu.
STEM-CELL RESEARCH BY: TROY HILKENS ROBBY LANGTON AND TODD SACHS.
Alexander Hanamean Ms. Harro Mentor: Dr. Tom Perkins MD. PhD.
Stem Cell Research. What are the purposes of stem cells? Inject stem cells into damaged tissue areas and stem cells regenerate damaged areas Being proposed.
CURING T1D IS A GLOBAL, COORDINATED EFFORT 555 ACTIVE RESEARCH PROJECTS Note: JDRF research portfolio review September 2014.
Medical Achievements Cancer, AIDS, Stem Cell. Cancer Achievements O Newer drugs seem to be making a bigger difference for small, specific groups of patients,
Nervous System Human Body Systems Project Caroline Crinion.
Cancer in Our Genes International Patient Database A patient-driven database dedicated to finding a cure for VHL and other cancers.
Biotechnology Research Project by Anna Dong, Soojin Jeong, Reina Ooka -Stem Cells-
High-Impact Research to Change Lives. LEARNING OBJECTIVES Participants should leave energized by progress occurring in MS research, and should be able.
© 2014 Direct One Communications, Inc. All rights reserved. 1 A New Era of Therapy in Multiple Sclerosis: Balancing the Options and Challenges Ahead Jennifer.
The Ethics of Stem Cell Research Presented by Corey Gomes Bme 181 April 15, 2013.
1 Transforming JDRF Research. Impacting Lives. Julia L. Greenstein, PhD AVP Cure Therapies April 10, 2012.
Dementia By: Kailie Glanovsky. What is it? It affects: ▫Memory ▫Thinking ▫ language ▫judgment ▫behavior Many people with this disease feel alone.
Experimental Gene Therapy Use On Humans. What is gene therapy? Gene therapy is a method of curing genetic disorders by introducing functioning genes into.
Present and Future Treatments for Retinal Degenerative Diseases: An Overview Gerald J. Chader Doheny Retina Institute USC Medical School Los Angeles, CA.
The Future of Cancer and Treatments Abby Bridge AP Biology Period 1.
Possible Cures/ Treatments Crohn’s Disease- Intestinal disease that causes pain and can sometimes lead to death. -Symptoms of interest: damaged intestinal.
Target: Treatment and Review.  Why do we consider some symptoms of schizophrenia “positive”?  What are some positive symptoms?  Take out your reference.
By TJ Wittmer Muscle weakness. Slurred speech. Also it is very difficult swallow.
What is gene therapy? Do now: In your own words,
Rheumatoid Arthritis Dr Chandini Rao Consultant Rheumatologist.
How To Design a Clinical Trial
PERSONALIZED MEDICINE AND IT’S RELEVANCE TO CANCER PATIENTS Casey Scarelli, Sallyann Vu, Jess Soule, Abrar Ahmed, Alief Imam.
Stem Cells (page 77-78) Tissues, Organs & Systems.
Dennis Bourdette, MD VA MS Center of Excellence-West and
Multiple Sclerosis By: Sandra Bachaalany MIM Virtual Camp Project.
MULTIPLE SCLEROSIS BY EMILY HOWARD. Multiple Sclerosis (MS) Multiple sclerosis (or MS) is a chronic, often disabling disease of the immune system that.
1 National Forum on Biomedical Imaging in Oncology CMS UPDATE Steve Phurrough MD, MPA Director, Coverage and Analysis Group.
Recent Studies Funded by the Progressive MS Alliance Tim Coetzee, PhD ACTRIMS 2016.
Remyelination Therapy for Multiple Sclerosis By Jordan Burnett With Dr. Gullo clerosis.jpg.
M ax D elbrück L ecture Date:June 17th, 2008 Speaker: Kenneth R. Chien MGH Cardiovascular Research Center Boston, USA Title:Toward human models of human.
STEM CELL TREATMENT IN INDIA Why to chose stem cell treatment in India?
Patient #4 - Parkinson’s Disease
How To Design a Clinical Trial
Multiple sclerosis: Oral Therapies and Beyond
By: Julie Carrasco, Brianna Macias, Alexx Rusake
Biomedical Therapies Foundation Standard 1: Academic Foundation
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Glaucoma.
Clinical Trials in IBD.
Why it Makes Sense to Travel Overseas for Stem Cell Therapy Treatment.
Changing the Game for Sjögren's Patients
Changing the IBD Paradigm
What Predicts Disability Progression in Multiple Sclerosis?
Current Controversies in Multiple Sclerosis Management
Neurostimulation for the Management of Medication-Resistant Epilepsy
Optimizing Patient Outcomes in IBD
IL-17 Inhibitors in the Management of Psoriatic Disease
Figure 3 Proportion of patients for whom NEDA
Stem Cells and Cellular Differentiation
Treating to Target in MS
The Burden of Psoriasis:
Pregnancy in MS.
By Brad Lee Science in the News.
Secondary Progressive Multiple Sclerosis: What Do We Know and Where Are We Heading?
Merging the Art and Science of Managing nOH in Clinical Practice
Presentation transcript:

Regional Update 2

Financial Report 3

Governance Report 4

Dr. Joel Pachter Progressive MS Update 5

Leukocytes enter the CNS during neuroinflammation

The blood-brain barrier is damaged during EAE/MS

Urgent Need to Find Solutions for People with Progressive MS 8 Large worldwide impact: about half of all MS patients Finding solutions for progressive MS is one of the top priorities for patients Currently paucity of effective DMT for progressive forms of MS Every time another therapy is approved for RRMS, a large proportion of our constituents feel left behind

Society Research Priorities 9 1.To better understand the biological basis for disease progression 2.To dissect the mechanisms of nerve damage and repair 3.To identify risk and triggering factors for MS 4.To enable development of new or improved rehabilitation techniques 5.To grow the global MS research enterprise $46 million in current commitments to progressive MS research

Progressive MS Research Initiatives 10 1.Over 100 investigator initiated research projects 2.MS Outcomes Assessment Consortium 3.Clinical Trials- MS SMART, SPRINT MS 4.SUMMIT natural history and risk factors study 5.Revision of Lublin-Reingold Clinical Course Descriptor 6.International Progressive MS Alliance

Mission To expedite the development of effective disease modifying and symptom management therapies for progressive forms of multiple sclerosis

Better extravasating of hES-MSC

Where is MS research going?  Novel drugs that act on “special” targets (e.g., CCL2)  Stem cell therapy with multifunctional “reparative” rather “replacement” cells Riluzole – sodium channel blocker Amiloride – diuretic/neuroprotective Ibudilast – anti-inlfammatory/neuroprotective

What FDA approved medications can we expect for secondary progressive MS, and when? When will oral therapies be available for progressive MS? I see your major research interests are blood brain barrier & neuroinflammation. How do you feel about these as treatment options? What do you suggest we look for when searching for a doctor to treat this? 16 Q&A Medications & Treatments

How soon are we going to see expansion of the stem cell clinical trials? Are clinical trails for stem cells taking place in the US? Will stem cell therapy become available and if so how would this therapy help any type of MS? 17 Q&A Stem Cells

What are the prospects for remylination? What progress has been made in RESTORING function, especially in patients who've had MS 20 years? 18 Q&A Restoring Function

What is the difference between the different types of MS? My daughter was recently diagnosed. As an undergraduate student starting to study MS, where is the best place to start? Will there ever be a cure for MS? Is it common for Parkinsons Disease and MS to occur in the same person? Is research being done around this? 19 Q&A General